104
Participants
Start Date
July 19, 2021
Primary Completion Date
October 17, 2022
Study Completion Date
December 31, 2025
Sunvozertinib
Daily dose of Sunvozertinib
Beijing Cancer Hospital, Beijing
Beijing Chest Hospital,Capital Medical University, Beijing
Peking Union Medical College Hospital, Beijing
Peking University Third Hospital, Beijing
Jilin Cancer Hospital, Changchun
Hunan Cancer Hospital(The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha
West China Hospital of Sichuan University, Chengdu
Army Medical Center of PLA, Chongqing
Chongqing University Cancer Hospital(Chongqing Cancer Hospital), Chongqing
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Hainan General Hospital, Haikou
The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital (Cancer Hospital of the University of Chinese Academy of Sciences), Hangzhou
Harbin Medical University Cancer Hospital, Harbin
The Second Hospital of Anhui Medical University, Hefei
The Affiliated Hospital of Inner Mongolia Medical University, Hohhot
Jinan Central Hospital (Central Hospital Affiliated to Shandong First Medical University), Jinan
Yunnan Cancer Hospital, Kunming
The First Affiliated Hospital of Nanchang University, Nanchang
The Second Affiliated Hospital of Nanchang University, Nanchang
Fudan University Shanghai Cancer Center, Shanghai
The First Hospital of China Medical University, Shenyang
The Fourth Hospital of Hebei Medical University, Shijiazhuang
The First Affiliated Hospital of Soochow University, Suzhou
Shanxi Provincial Cancer Hospital, Taiyuan
Tianjin Medical University Cancer Institute & Hospital, Tianjin
The Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi
Hubei Cancer Hospital, Wuhan
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Affiliated Cancer Hospital of Zhengzhou University(Henan Cancer Hospital), Zhengzhou
Lead Sponsor
Dizal Pharmaceuticals
INDUSTRY